|
Back to Home » June 2019 News » Biotech Brief: Atopic Dermatitis (Eczema) Revenues Projected to Exceed $6 Billion by 2022 |
Biotech Brief: Atopic Dermatitis (Eczema) Revenues Projected to Exceed $6 Billion by 2022 |
June 12, 2019
PALM BEACH, Florida, June 11, 2019 /PRNewswire/ -- Recent reports by industry specialists show that the Atopic Dermatitis Drugs Market Size Worth $6.41 Billion By 2022, exhibiting a CAGR of 6.6% during the forecast period. This is an increase from the 2016 market revenues when The global...
Source URL: https://www.prnewswire.com:443/news-releases/biotech-brief-atopic-dermatitis-eczema-revenues-projected-to-exceed-6-billion-by-2022-300865122.html
|
|
|
|
